Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Int Immunopharmacol ; 128: 111499, 2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38232535

ABSTRACT

BACKGROUND AND AIMS: S100a10 is a member of the S100 family of proteins, which plays a key role in the depression and tumor metastasis. However, the role of S100a10 is unclear in ulcerative colitis. METHODS: The effect of S100a10 was assessed using a murine ulcerative colitis model which was accompanied by parameters including body weight loss, disease activity index, histological score, colon weight and length. The quantity and role of immune cells was determined by flow cytometry and bone marrow chimeric mice. Neutrophils depletion, adoptive cell transfer and conditional knockout mice were used to ascertain which cells played the key role in ulcerative colitis. The function of neutrophils was evaluated by migration assay, phagocytosis assay, multiplex immunoassay and real-time PCR. RESULTS: In this study, our data showed that S100a10-/- mice were prone to ulcerative colitis induced by dextran sodium sulfate. Neutrophils number increased in colon of S100a10-/- mice after dextran sodium sulfate treatment significantly. Meanwhile, adoptive transfer of neutrophils from wild type mice partially decreased the susceptibility of S100a10-/- mice to dextran sodium sulfate. There was no difference in ulcerative colitis between the groups of S100a10-/- mice without neutrophils and wild type mice. Finally, we found that S100a10-/- neutrophils had stronger function in secretion and synthesis of inflammatory factor. CONCLUSIONS: In one word, these results suggest that S100a10 has a role in inhibiting the pathogenesis of ulcerative colitis through regulation of neutrophils function.


Subject(s)
Colitis, Ulcerative , Colitis , Sulfates , Animals , Mice , Colitis/chemically induced , Colitis, Ulcerative/pathology , Colon/pathology , Dextran Sulfate/pharmacology , Dextrans/adverse effects , Dextrans/metabolism , Disease Models, Animal , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/metabolism
2.
J Med Virol ; 95(1): e28176, 2023 01.
Article in English | MEDLINE | ID: mdl-36163615

ABSTRACT

Hydrogen sulfide (H2 S) is a redox gasotransmitter. It has been shown that H2 S has a key role in host antiviral defense by inhibiting interleukin production and S-sulfhydrating Keap1 lead to Nrf2/ARE pathway activation. However, it is yet unclear whether H2 S can play an antiviral role by regulating autophagy. In this study, we found that exogenous H2 S decreased the expression of human T-cell leukemia virus type-1 (HTLV-1) protein and HTLV-1 induced autophagosomes accumulation. Transmission electron microscope assays indicated that autophagosomes accumulation decreased after H2 S administration. HTLV-1-transformed T-cell lines had a high level of CSE (H2 S endogenous enzyme) which could be induced in Hela by HTLV-1 infection. Immunoblot demonstrated that overexpression of CSE inhibited HTLV-1 protein expression and autophagy. And we got the opposite after CSE knockdown. Meanwhile, H2 S could not restrain the autophagy when ATG4B had a mutant at its site of 89. In a word, these results suggested that H2 S modulated HTLV-1 protein expression via ATG4B. Therefore, our findings suggested a new mechanism by which H2 S defended against virus infection.


Subject(s)
Human T-lymphotropic virus 1 , Hydrogen Sulfide , Leukemia, T-Cell , Humans , Human T-lymphotropic virus 1/physiology , Hydrogen Sulfide/pharmacology , Hydrogen Sulfide/metabolism , Kelch-Like ECH-Associated Protein 1/metabolism , NF-E2-Related Factor 2/metabolism , Antiviral Agents/metabolism , Autophagy-Related Proteins/genetics , Cysteine Endopeptidases/metabolism
3.
Nanomaterials (Basel) ; 12(17)2022 Aug 31.
Article in English | MEDLINE | ID: mdl-36080060

ABSTRACT

Amphiphilic core-shell (ACS) nanoparticles are gaining increasing research interest for multi-drug delivery in cancer therapy. In this work, a new cationic peptide-coated PHA nanosphere was prepared by self-assembly of a hydrophobic core of biodegradable poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) and a hydrophilic shell of fusion proteins of PHA granule-associated protein (PhaP) and cationic peptide RALA through a strong hydrophobic effect. The hydrophobic drug curcumin (Cur) was encapsulated in PHBHHx nanoparticles. The chemotherapy drug 5-fluorouracil (5-FU) was administered in the form of its metabolite oligomeric 5-fluorodeoxyuridine (FUdR). Fifteen consecutive FUdR (FUdR15S) were adsorbed on the surface of PHBHHx nanoparticles by electrostatic interaction with RALA to form Cur@PHBX-PR/FUdR15S. Such amphiphilic cationic nanospheres had 88.3% EE of Cur and the drug loading of Cur and FUdR were 7.8% and 12.1%. The dual-drug-loaded nanospheres showed a time-differential release of Cur and FUdR. In addition, Cur@PHBX-PR/FUdR15S exhibited excellent anticancer activity and played a vital role in promoting the synergistic effect of FUdR and Cur in gastric cancer cells. The exploration of antitumor mechanisms demonstrated that Cur improved the activity of apoptosis-related proteins and cancer cells sensitized to FUdR. This amphiphilic core-shell system can serve as a general platform for sequential delivery of multiple drugs to treat several cancer cells.

4.
Cell Mol Immunol ; 17(10): 1053-1062, 2020 10.
Article in English | MEDLINE | ID: mdl-31467414

ABSTRACT

Toll-like receptors (TLRs) are key pattern recognition receptors that mediate innate immune responses to infection. However, uncontrolled TLR activation can lead to severe inflammatory disorders such as septic shock. The molecular mechanisms through which TLR responses are regulated are not fully understood. Here, we demonstrate an essential function of S100A10 in TLR signaling. S100A10 was constitutively expressed in macrophages, but was significantly downregulated upon TLR activation. S100A10-deficient macrophages were hyperresponsive to TLR stimulation, and S100A10-deficient mice were more sensitive to endotoxin-induced lethal shock and Escherichia coli-induced abdominal sepsis. Mechanistically, S100A10 regulated macrophage inflammatory responses by interfering with the appropriate recruitment and activation of the receptor-proximal signaling components and eventually inhibited TLR-triggered downstream signaling. These findings expand our understanding of TLR signaling and establish S100A10 as an essential negative regulator of TLR function and a potential therapeutic target for treating inflammatory diseases.


Subject(s)
Annexin A2/metabolism , Escherichia coli Infections/immunology , Escherichia coli Infections/metabolism , Immunity , S100 Proteins/metabolism , Signal Transduction , Toll-Like Receptors/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Animals , Annexin A2/deficiency , Cytokines/biosynthesis , Escherichia coli/physiology , Escherichia coli Infections/microbiology , Humans , Inflammation/pathology , Inflammation Mediators/metabolism , Lipopolysaccharides , Macrophages/metabolism , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/metabolism , Phagocytosis/drug effects , Protein Binding , Protein Domains , S100 Proteins/deficiency , Sepsis/pathology , Toll-Like Receptor 4/chemistry , Toll-Like Receptor 4/metabolism
5.
Sci Rep ; 8(1): 6064, 2018 04 17.
Article in English | MEDLINE | ID: mdl-29666504

ABSTRACT

The Chinese government has issued the policy of promulgating the clinical use of antibacterial drugs since 2011. Prophylactic antibiotic use is a challenging problem among young children with intussusception after successful air enema reduction. There were limited data regarding the clinical value of prophylactic antibiotics for intussusception with low-risk infections. A retrospective non-randomized comparative study was conducted among 188 young children with intussusception after successful air enema reduction between January 1, 2011 and December 30, 2013. Among these children, 51 received prophylactic antibiotics and 137 did not receive antibiotics. Our results showed that there were no significant differences in age, gender, weight, admission period, reduction interval, axillary temperature, leukocytes, neutrophils, lymphocytes, monocytes, mesenteric lymph nodes and complications between groups (P > 0.05). The national policy had significantly improved clinical use of antibiotic for young children with low-risk intussusception (OR < 0.001, P < 0.001). Inpatients days were longer for children used antibiotics than those who did not (median, 27.0 hours vs 21.0 hours, P = 0.003). Prophylactic antibiotics appeared to be of little value after the successful air enema reduction of intussusception in young children with low-risk infection. Policy intervention is effective for antibiotic use in China.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Intussusception/therapy , Antibiotic Prophylaxis , Child, Preschool , China/epidemiology , Enema/adverse effects , Enema/methods , Female , Humans , Infant , Infection Control , Infections/etiology , Intussusception/etiology , Male , Retrospective Studies , Risk Factors , Treatment Outcome
6.
BMC Cancer ; 16: 538, 2016 07 26.
Article in English | MEDLINE | ID: mdl-27460922

ABSTRACT

Breast cancer causes the No.1 women cancer prevalence and the No.2 women cancer mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays important roles in breast cancer pathogenesis and evolution, such as estrogen receptor α (ERα/ESR1), tumor protein p53 (p53/TP53) and Nuclear factor kappa B (NFκB). About 60-70 % of breast tumors are ERα positive, while approximate 70 % of breast tumors are P53 wild type. Recent studies indicate that nuclear receptors/transcriptional factors could be tightly controlled through protein post-translational modification.The nuclear receptors/transcriptional factors could endure several types of modifications, including phosphorylation, acetylation and ubiquitination. Compared with the other two types of modifications, ubiquitination was mostly linked to protein degradation process, while few researches focused on the functional changes of the target proteins. Until recent years, ubiquitination process is no longer regarded as merely a protein degradation process, but aslo treated as one kind of modification signal.As an atypical E3 ubiquitin ligase, RNF31 was previously found to facilitate NFκB signaling transduction through linear ubiquitination on IKKγ(IκB kinase γ). Our previous studies showed important regulatory functions of RNF31 in controlling important oncogenic pathways in breast cancer, such as ERα and p53. This review highlights recent discoveries on RNF31 functions in nuclear factor modifications, breast cancer progression and possible therapeutic inhibitors targeting RNF31.


Subject(s)
Breast Neoplasms/metabolism , Estrogen Receptor alpha/metabolism , NF-kappa B/metabolism , Tumor Suppressor Protein p53/metabolism , Ubiquitin-Protein Ligases/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Disease Progression , Female , Humans , Molecular Targeted Therapy , Signal Transduction , Ubiquitin-Protein Ligases/antagonists & inhibitors , Ubiquitination
7.
J Hematol Oncol ; 9: 13, 2016 Feb 24.
Article in English | MEDLINE | ID: mdl-26912146

ABSTRACT

BACKGROUND: Our previous pilot studies aimed to examine the role of hydrogen sulfide (H2S) in the generation of endothelial progenitor cells led to an unexpected result, i.e., H2S promoted the differentiation of certain hematopoietic stem/progenitor cells in the bone marrow. This gave rise to an idea that H2S might promote hematopoiesis. METHODS: To test this idea, a mice model of myelosuppression and cultured fetal liver cells were used to examine the role of H2S in hematopoiesis. RESULTS: H2S promoted the generation of megakaryocytes, increased platelet levels, ameliorate entorrhagia, and improved survival. These H2S effects were blocked in both in vivo and in vitro models with thrombopoietin (TPO) receptor knockout mice (c-mpl(-/-) mice). In contrast, H2S promoted megakaryocytes/platelets generation in both in vivo and in vitro models with TPO knockout mice (TPO(-/-) mice). CONCLUSIONS: H2S is a novel promoter for megakaryopoiesis by acting on the TPO receptors but not TPO to generate megakaryocytes/platelets.


Subject(s)
Blood Platelets/drug effects , Hematopoiesis/drug effects , Hydrogen Sulfide/pharmacology , Megakaryocytes/drug effects , Animals , Blood Platelets/metabolism , Blood Platelets/radiation effects , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Differentiation/radiation effects , Cells, Cultured , Dose-Response Relationship, Drug , Fetus/cytology , Hematopoiesis/genetics , Hematopoiesis/radiation effects , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Hematopoietic Stem Cells/radiation effects , Liver/cytology , Liver/drug effects , Liver/metabolism , Megakaryocytes/metabolism , Megakaryocytes/radiation effects , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Confocal , Microscopy, Electron, Scanning , Receptors, Thrombopoietin/genetics , Receptors, Thrombopoietin/metabolism , Sulfides/pharmacology , Survival Analysis , Thrombopoietin/genetics , Thrombopoietin/metabolism , Thrombopoietin/pharmacology
8.
PLoS One ; 10(11): e0142999, 2015.
Article in English | MEDLINE | ID: mdl-26569111

ABSTRACT

China introduced a new policy regarding the management of antibiotic use. We evaluated the reasonableness of antibiotic use among children suffering from intussusception before and after policy. A retrospective study was conducted involving 234 young children with intussusception who were treated between January 1, 2011 and December 30, 2013. Demographics and detailed antibiotics regimens were collected. χ2 test was used to evaluate differences between the phase I (preintervention, n = 68) and phase II (postintervention, n = 166). We determined that the overall antibiotic use rate following successful air enema reduction was 41% (97/234), which decreased from 99% (67/68) in phase I to 18% (30/166) in phase II. In phase I, prophylactic antibiotic usage reached up to 84% (56/67). The quantity of aztreonam for injection accounted for 63% (45/71), and cefamandole nafate for injection accounted for 25% (18/71). In phases II, prophylactic antibiotic usage were reduced to 13% (4/30). The quantity of aztreonam for injection was decreased to 12% (4/33) and cefamandole nafate for injection was 3% (1/33). Antibiotics' options were more diverse. In conclusion, policy intervention was effective in addressing some aspects of antibacterial drug usage among young children with intussusception. However, excessive drug use remains a public health problem. The guidelines for the antibiotic management of intussusception for children must be established in China.


Subject(s)
Air , Anti-Bacterial Agents/therapeutic use , Enema , Intussusception/drug therapy , Child, Preschool , Female , Humans , Infant , Male , Prescription Drugs/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...